These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8386710)

  • 1. Regulation of urokinase-type plasminogen activator expression in squamous-cell carcinoma of the oral cavity.
    Clayman G; Wang SW; Nicolson GL; el-Naggar A; Mazar A; Henkin J; Blasi F; Goepfert H; Boyd DD
    Int J Cancer; 1993 Apr; 54(1):73-80. PubMed ID: 8386710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer cell expression of urokinase-type plasminogen activator receptor mRNA in squamous cell carcinomas of the skin.
    Rømer J; Pyke C; Lund LR; Ralfkiaer E; Danø K
    J Invest Dermatol; 2001 Mar; 116(3):353-8. PubMed ID: 11231307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of urokinase-type plasminogen activator expression by an ERK1-dependent signaling pathway in a squamous cell carcinoma cell line.
    Lengyel E; Gum R; Stepp E; Juarez J; Wang H; Boyd D
    J Cell Biochem; 1996 Jun; 61(3):430-43. PubMed ID: 8761947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.
    Yoshizawa K; Nozaki S; Kitahara H; Kato K; Noguchi N; Kawashiri S; Yamamoto E
    Oncol Rep; 2011 Dec; 26(6):1555-60. PubMed ID: 21833477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular distribution and clinical value of urokinase-type plasminogen activator, its receptor, and plasminogen activator inhibitor-2 in esophageal squamous cell carcinoma.
    Shiomi H; Eguchi Y; Tani T; Kodama M; Hattori T
    Am J Pathol; 2000 Feb; 156(2):567-75. PubMed ID: 10666386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urokinase receptor up-regulation in head and neck squamous cell carcinoma.
    Schmidt M; Schler G; Gruensfelder P; Müller J; Hoppe F
    Head Neck; 2000 Aug; 22(5):498-504. PubMed ID: 10897110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of invasion and metastasis in oral cancer by targeting urokinase-type plasminogen activator receptor.
    Nozaki S; Endo Y; Nakahara H; Yoshizawa K; Hashiba Y; Kawashiri S; Tanaka A; Nakagawa K; Matsuoka Y; Kogo M; Yamamoto E
    Oral Oncol; 2005 Nov; 41(10):971-7. PubMed ID: 16129656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of urokinase-related genes in superficial and invasive transitional cell carcinoma.
    McGarvey TW; Kariko K; Barnathan ES; Thomas J; Malkowicz SB
    Int J Oncol; 1998 Jan; 12(1):175-80. PubMed ID: 9454902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urokinase and the urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines.
    Hudson MA; McReynolds LM
    J Natl Cancer Inst; 1997 May; 89(10):709-17. PubMed ID: 9168186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UVB increases urokinase-type plasminogen activator receptor (uPAR) expression.
    Marschall C; Lengyel E; Nobutoh T; Braungart E; Douwes K; Simon A; Magdolen V; Reuning U; Degitz K
    J Invest Dermatol; 1999 Jul; 113(1):69-76. PubMed ID: 10417621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional activation of the urokinase receptor gene in invasive colon cancer.
    Wang H; Skibber J; Juarez J; Boyd D
    Int J Cancer; 1994 Sep; 58(5):650-7. PubMed ID: 8077048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential mRNA expression of urokinase-type plasminogen activator, plasminogen activator receptor and plasminogen activator inhibitor type-2 in normal human endometria and endometrial carcinomas.
    Foca C; Moses EK; Quinn MA; Rice GE
    Gynecol Oncol; 2000 Nov; 79(2):244-50. PubMed ID: 11063652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased urokinase receptor levels in human gastrointestinal neoplasia and related liver metastases.
    Sier CF; Quax PH; Vloedgraven HJ; Verheijen JH; Griffioen G; Ganesh S; Lamers CB; Verspaget HW
    Invasion Metastasis; 1993; 13(6):277-88. PubMed ID: 7860221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of urokinase-type plasminogen activator receptor is correlated with metastases of lingual squamous cell carcinoma.
    Wang J; Guo F; Wei H; Dong J; Wu J
    Br J Oral Maxillofac Surg; 2006 Dec; 44(6):515-9. PubMed ID: 16356605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro urokinase type plasminogen activator levels and total plasminogen activator activity in squamous cell carcinomas of the head and neck.
    Petruzzelli GJ; Snyderman CH; Johnson JT
    Arch Otolaryngol Head Neck Surg; 1994 Sep; 120(9):989-92. PubMed ID: 8074827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of PD 098059, a specific inhibitor of mitogen-activated protein kinase kinase, on urokinase expression and in vitro invasion.
    Simon C; Juarez J; Nicolson GL; Boyd D
    Cancer Res; 1996 Dec; 56(23):5369-74. PubMed ID: 8968087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the plasminogen activation system in kidney cancer correlates with its aggressive phenotype.
    Swiercz R; Wolfe JD; Zaher A; Jankun J
    Clin Cancer Res; 1998 Apr; 4(4):869-77. PubMed ID: 9563880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role and regulation of expression of 92-kDa type-IV collagenase (MMP-9) in 2 invasive squamous-cell-carcinoma cell lines of the oral cavity.
    Juarez J; Clayman G; Nakajima M; Tanabe KK; Saya H; Nicolson GL; Boyd D
    Int J Cancer; 1993 Aug; 55(1):10-8. PubMed ID: 7688350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and alpha(2)-macroglobulin receptor in human breast carcinomas.
    Christensen L; Wiborg Simonsen AC; Heegaard CW; Moestrup SK; Andersen JA; Andreasen PA
    Int J Cancer; 1996 May; 66(4):441-52. PubMed ID: 8635858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In situ gene expression of urokinase-type plasminogen activator and its receptor in transitional cell carcinoma of the human bladder.
    Bhuvarahamurthy V; Schroeder J; Denkert C; Kristiansen G; Schnorr D; Loening SA; Jung K; Staack A
    Oncol Rep; 2004 Oct; 12(4):909-13. PubMed ID: 15375521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.